COPENHAGEN, April 23 /PRNewswire-FirstCall/ -- Summary: At Genmab A/S' Annual General Meeting held today on April 23, 2008 the Annual Report for 2007 was approved, discharge was given to the Board of Directors and the Management and the year's loss was carried forward. Two members of the Board of Directors were re-elected and PricewaterhouseCoopers was re-elected as auditor of the Company. The proposals from the Board of Directors to change the Articles of Association and authorization to allow the Company to purchase shares in the Company were adopted.
Genmab A/S (OMX: GEN) held its Annual General Meeting, today April 23, 2008 at 3:00 pm at Radisson SAS Scandinavia Hotel, Amager Boulevard 70, 2300 Copenhagen S, Denmark.
At the meeting Chairman of the Board Dr. Michael B. Widmer gave - on behalf of the Board - a report on the Company's activities during the past year. Chief Executive Officer and member of the Board, Lisa N. Drakeman presented plans for the year ahead, and Chief Financial Officer Bo Kruse presented the Annual Report for 2007 endorsed by the auditors. The report was approved and discharge was given to the Board and the Management.
It was decided that the year's loss of DKK 373 million be carried forward by transfer to accumulated deficit, as stated in the Annual Report.
Michael B. Widmer and Karsten Havkrog Pedersen were re-elected to the Board for a further three year period.
PricewaterhouseCoopers, Statsautoriseret Revisionsaktieselskab A/S was reelected as the Company's auditor.
The General Meeting adopted the proposals from the Board to change the Company's Articles of Association, as follows:
- The proposals to remove the current Article 5, Article 6 and Schedule A and to make the consequent amendments to the Articles of Association.
The proposal to amend Article 5 (previously Article 6A) to authorize
the Board of Directors to issue additional warrants - without pre-emption
|SOURCE Genmab A/S|
Copyright©2008 PR Newswire.
All rights reserved